Symeonidion Research Center, Theagenion Cancer Hospital, Thessaloniki, Greece.
Anticancer Res. 2010 Oct;30(10):4201-4.
Modified steroidal derivatives (PK11-PK14) of p-bis(2-chloroethyl)aminophenyl propenate (PK15) were used to study their antitumour activity on Lewis lung carcinoma (LLC) and their effect on sister chromatid exchanges (SCEs) and human lymphocyte proliferation kinetics.
LLC was tested in this study. C57BL mice were used for in vivo chemotherapy evaluation and the antitumour activity was assessed. Lymphocyte cultures were used to study the genotoxic effect in vitro.
PK15 and PK11 were the most effective against LLC, causing significant inhibition of tumour growth. PK11 and PK15 induced significant increase in SCE rates. A correlation was observed between the cytogenetic effect and the antitumour effectiveness.
The order of the antitumour effectiveness of PK11-PK15 resembled the order of the cytogenetic damage induced by the same compounds in vitro.
对 p-双(2-氯乙基)氨苯基丙烯酸盐(PK15)进行了改良的甾体衍生物(PK11-PK14)研究,以研究它们对 Lewis 肺癌(LLC)的抗肿瘤活性及其对姐妹染色单体交换(SCE)和人淋巴细胞增殖动力学的影响。
本研究中测试了 LLC。C57BL 小鼠用于体内化疗评估,并评估抗肿瘤活性。淋巴细胞培养用于体外研究遗传毒性作用。
PK15 和 PK11 对 LLC 最有效,导致肿瘤生长明显抑制。PK11 和 PK15 诱导 SCE 率显著增加。细胞遗传学效应与抗肿瘤效果之间存在相关性。
PK11-PK15 的抗肿瘤效果顺序与相同化合物在体外引起的细胞遗传学损伤顺序相似。